Vista Pharmaceuticals Ltd (524711):企業の財務・戦略的SWOT分析

◆英語タイトル:Vista Pharmaceuticals Ltd (524711) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15150
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vista Pharmaceuticals Ltd (Vista), a subsidiary of Torrent Pharmaceuticals Ltd, is a pharmaceutical company that offers over the counter and prescription generic products. The company offers drugs in the form of tablets, capsules and liquids for various therapeutic areas. It offers products such as sulfamethoxazole and trimethoprim, isoxsuprine HCL, sulfamethoxazole and trimethoprim, bismuth subsalicylate, bismuth subgallate and pyrantel pamoate, among others. Vista also offers aspirin, atenolol, cotrimoxazole, chloroquine phosphate, captopril, carbamazipine, frusemide, glibenclamide, ibuprofen, methyldopa, mebendazole, metronidazole, nefidipine, paracetamol, pyrimethamine and sulfadiazine, among others. The company has operations in India and the US. Vista is headquartered in Hyderabad, Telangana, India.

Vista Pharmaceuticals Ltd Key Recent Developments

Feb 24,2018: Vista Pharmaceuticals Announces Board Changes
Feb 10,2018: vista Pharmaceuticals had an USFDA Inspection and issued with Observations

This comprehensive SWOT profile of Vista Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vista Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Vista Pharmaceuticals Ltd – Key Information
Vista Pharmaceuticals Ltd – Overview
Vista Pharmaceuticals Ltd – Key Employees
Vista Pharmaceuticals Ltd – Key Employee Biographies
Vista Pharmaceuticals Ltd – Key Operational Heads
Vista Pharmaceuticals Ltd – Major Products and Services
Vista Pharmaceuticals Ltd – History
Vista Pharmaceuticals Ltd – Company Statement
Vista Pharmaceuticals Ltd – Locations And Subsidiaries
Vista Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Vista Pharmaceuticals Ltd – Business Description
Vista Pharmaceuticals Ltd – Corporate Strategy
Vista Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Vista Pharmaceuticals Ltd – Strengths
Vista Pharmaceuticals Ltd – Weaknesses
Vista Pharmaceuticals Ltd – Opportunities
Vista Pharmaceuticals Ltd – Threats
Vista Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Vista Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Vista Pharmaceuticals Ltd, Key Information
Vista Pharmaceuticals Ltd, Key Ratios
Vista Pharmaceuticals Ltd, Share Data
Vista Pharmaceuticals Ltd, Major Products and Services
Vista Pharmaceuticals Ltd, History
Vista Pharmaceuticals Ltd, Key Employees
Vista Pharmaceuticals Ltd, Key Employee Biographies
Vista Pharmaceuticals Ltd, Key Operational Heads
Vista Pharmaceuticals Ltd, Other Locations
Vista Pharmaceuticals Ltd, Subsidiaries
Vista Pharmaceuticals Ltd, Key Manufacturing facilities
Vista Pharmaceuticals Ltd, Key Competitors
Vista Pharmaceuticals Ltd, SWOT Analysis
Vista Pharmaceuticals Ltd, Ratios based on current share price
Vista Pharmaceuticals Ltd, Annual Ratios
Vista Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Vista Pharmaceuticals Ltd, Performance Chart
Vista Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Vista Pharmaceuticals Ltd (524711):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genetic Signatures Ltd (GSS):医療機器:M&Aディール及び事業提携情報
    Summary Genetic Signatures Ltd (Genetic Signatures), formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company. The company designs and manufactures real-time polymerase chain reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. It of …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • PPL Corporation:企業の戦略・SWOT・財務情報
    PPL Corporation - Strategy, SWOT and Corporate Finance Report Summary PPL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NTPC Ltd (NTPC):電力:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • West Pharmaceutical Services Inc (WST)-医療機器分野:企業M&A・提携分析
    Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals fo …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • National Institute of Agricultural Research-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various co …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Hanger, Inc. (HNGR):企業の財務・戦略的SWOT分析
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Genesis Energy Ltd (GNE):電力:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Questerre Energy Corp (QEC):企業の財務・戦略的SWOT分析
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …
  • Sermonix Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sermonix Pharmaceuticals LLC (Sermonix) is a biotechnology company develops female-specific oncology products. The company provides lead product such as lasofoxifene, which is a selective estrogen receptor modulator. Its lasofoxifene is used in the treatment of common disorders affecting wom …
  • Baxter International Inc (BAX)-製薬・医療分野:企業M&A・提携分析
    Summary Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products for the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-cent …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ERG SpA (ERG):企業の財務・戦略的SWOT分析
    ERG SpA (ERG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Orsted AS (ORSTED):電力:M&Aディール及び事業提携情報
    Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and …
  • Spritzer Bhd:企業の戦略・SWOT・財務情報
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ProMIS Neurosciences Inc (PMN):医療機器:M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆